Multiple hybrid immunoassay
US10641767B2 · kind B2 · utility
0Cited by
41References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2018 |
| Grant date | May 5, 2020 |
| Priority date | — |
| Expiry date | May 9, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/324
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to compositions and methods for the immunoassay of an analyte of interest. The analyte is detected in an immunoassay using three or more antibodies, where in each antibody specifically binds to a different epitope on the analyte. When the analyte of interest in a clinical marker for an acute disease, the detection of the analyte by immunoassay is a diagnosis of the occurrence of the disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.